Nebulizers, Inhalers and Respirators for Asthma Treatment Market Report

Global and Region Nebulizers, Inhalers and Respirators for Asthma Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：138
  • REPORT CODE：GMM899604
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Asthma is a chronic inflammatory lung disease which affects persons across all ages. It creates inflammation inside the walls of airways, causing airways to narrow, swell and produce extra mucous. It is caused due to genetic factors or environmental triggers, or a combination of both. Some of the symptoms of asthma are: Coughing, wheezing, trouble in breathing and tightness or pain in the chest.

    North America dominates the global market for nebulizers, inhalers and respirators for asthma treatment due to a rapid rise in the aging population and developed healthcare infrastructure in the region. Asia Pacific is expected to show high growth rates over the next few years in the global nebulizers, inhalers and respirators for asthma treatment market, with China and India being the fastest-growing markets in the Asia Pacific region.

    The report details the trend, potential and market size of Nebulizers, Inhalers and Respirators for Asthma Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nebulizers, Inhalers and Respirators for Asthma Treatmentmarket, defines the market attractiveness level of Nebulizers, Inhalers and Respirators for Asthma Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nebulizers, Inhalers and Respirators for Asthma Treatment industry, describes the types of Nebulizers, Inhalers and Respirators for Asthma Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nebulizers, Inhalers and Respirators for Asthma Treatment market and the development prospects and opportunities of Nebulizers, Inhalers and Respirators for Asthma Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nebulizers, Inhalers and Respirators for Asthma Treatment market in Chapter 13.

    By Player:

    • 3M Healthcare

    • Drive DeVilbiss Healthcare

    • Astrazeneca

    • Yuwell

    • Boehringer Ingelheim

    • Invacare

    • GF Health Products

    • Philips Respironics

    • Omron

    • PARI GmbH

    • GlaxoSmithKline

    • Drager

    By Type:

    • Nebulizers

    • Inhalers

    • Respirators

    By End-User:

    • Hospitals

    • Clinics

    • Home Care

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nebulizers, Inhalers and Respirators for Asthma Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nebulizers, Inhalers and Respirators for Asthma Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nebulizers, Inhalers and Respirators for Asthma Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nebulizers, Inhalers and Respirators for Asthma Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nebulizers, Inhalers and Respirators for Asthma Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption (2017-2022)

    • 7.2 United States Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption (2017-2022)

    • 7.3 Europe Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption (2017-2022)

    • 7.4 China Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption (2017-2022)

    • 7.5 Japan Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption (2017-2022)

    • 7.6 India Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption (2017-2022)

    • 7.7 South Korea Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption (2017-2022)

    8 Region and Country-wise Nebulizers, Inhalers and Respirators for Asthma Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast (2022-2028)

    • 8.4 China Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast (2022-2028)

    • 8.6 India Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast (2022-2028)

    9 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Nebulizers Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Inhalers Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Respirators Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Nebulizers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Inhalers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Respirators Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nebulizers, Inhalers and Respirators for Asthma Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Competitive Analysis

    • 14.1 3M Healthcare

      • 14.1.1 3M Healthcare Company Details

      • 14.1.2 3M Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 3M Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.2 Drive DeVilbiss Healthcare

      • 14.2.1 Drive DeVilbiss Healthcare Company Details

      • 14.2.2 Drive DeVilbiss Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Drive DeVilbiss Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.3 Astrazeneca

      • 14.3.1 Astrazeneca Company Details

      • 14.3.2 Astrazeneca Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Astrazeneca Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.4 Yuwell

      • 14.4.1 Yuwell Company Details

      • 14.4.2 Yuwell Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Yuwell Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.5 Boehringer Ingelheim

      • 14.5.1 Boehringer Ingelheim Company Details

      • 14.5.2 Boehringer Ingelheim Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Boehringer Ingelheim Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.6 Invacare

      • 14.6.1 Invacare Company Details

      • 14.6.2 Invacare Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Invacare Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.7 GF Health Products

      • 14.7.1 GF Health Products Company Details

      • 14.7.2 GF Health Products Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GF Health Products Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.8 Philips Respironics

      • 14.8.1 Philips Respironics Company Details

      • 14.8.2 Philips Respironics Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Philips Respironics Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.9 Omron

      • 14.9.1 Omron Company Details

      • 14.9.2 Omron Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Omron Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.10 PARI GmbH

      • 14.10.1 PARI GmbH Company Details

      • 14.10.2 PARI GmbH Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 PARI GmbH Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.11 GlaxoSmithKline

      • 14.11.1 GlaxoSmithKline Company Details

      • 14.11.2 GlaxoSmithKline Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 GlaxoSmithKline Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • 14.12 Drager

      • 14.12.1 Drager Company Details

      • 14.12.2 Drager Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Drager Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nebulizers, Inhalers and Respirators for Asthma Treatment

    • Figure Nebulizers, Inhalers and Respirators for Asthma Treatment Picture

    • Table Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nebulizers, Inhalers and Respirators for Asthma Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption by Country (2017-2022)

    • Figure United States Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nebulizers, Inhalers and Respirators for Asthma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nebulizers Consumption and Growth Rate (2017-2022)

    • Figure Global Inhalers Consumption and Growth Rate (2017-2022)

    • Figure Global Respirators Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Home Care Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Nebulizers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inhalers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Respirators Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nebulizers, Inhalers and Respirators for Asthma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nebulizers, Inhalers and Respirators for Asthma Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table 3M Healthcare (Foundation Year, Company Profile and etc.)

    • Table 3M Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table Drive DeVilbiss Healthcare (Foundation Year, Company Profile and etc.)

    • Table Drive DeVilbiss Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Drive DeVilbiss Healthcare Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table Astrazeneca (Foundation Year, Company Profile and etc.)

    • Table Astrazeneca Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table Yuwell (Foundation Year, Company Profile and etc.)

    • Table Yuwell Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yuwell Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table Invacare (Foundation Year, Company Profile and etc.)

    • Table Invacare Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Invacare Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table GF Health Products (Foundation Year, Company Profile and etc.)

    • Table GF Health Products Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GF Health Products Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table Philips Respironics (Foundation Year, Company Profile and etc.)

    • Table Philips Respironics Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Philips Respironics Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table Omron (Foundation Year, Company Profile and etc.)

    • Table Omron Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omron Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table PARI GmbH (Foundation Year, Company Profile and etc.)

    • Table PARI GmbH Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table PARI GmbH Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service

    • Table Drager (Foundation Year, Company Profile and etc.)

    • Table Drager Nebulizers, Inhalers and Respirators for Asthma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Drager Nebulizers, Inhalers and Respirators for Asthma Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US